Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV anti CD40 env gp 140 vaccine - EnnoDC

Next Previous
Drug Profile

HIV anti CD40 env gp 140 vaccine - EnnoDC

Alternative Names: CD40.HIVRI.Env; Env GP140 HIV vaccine; Env-GP140-HIV; HIV ANTI CD 40 ENV GP 140; HIV ANTI-CD40.ENV GP140

Latest Information Update: 28 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vaccine Research Institute
  • Developer EnnoDC
  • Class Protein vaccines; Recombinant fusion proteins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I HIV infections

Most Recent Events

  • 28 Feb 2025 HIV anti CD40 env gp 140 vaccine is still in phase-I development in HIV-infections (Prevention) in Switzerland and France (SC, Injection) (NCT04842682) (EnnoDC pipeline, February 2025)
  • 28 Oct 2024 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in France (SC, Injection)
  • 28 Oct 2024 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in Switzerland (SC, Injection)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top